The Indian pharmaceutical market size is USD 65 billion by 2024 and will grow into a massive USD 450 billion industry by 2047, as per reports.
Medistep Healthcare has been part of this journey for a long time and now it is going public.
The Medistep Healthcare IPO manager is Fast Track Finsec and the registrar is Cameo Corporate. Click here to know your allotment status.
See the Medistep Healthcare IPO RHP for more details.
Note: Half of Medistep Healthcare IPO’s shares will be unlocked 30 days after allotment, while the rest will be free from lock-in restrictions after 90 days.
If you’re considering investing in this IPO, see all the key information we've gathered here.
Make sure your demat account is ready and linked with your trading account. Check with your broker for quick access.
Here's a detailed plan of the amount it will use for expansion and working capital. This can be used to get the Medistep healthcare IPO review today.
The strengths and risks of the company are mentioned below.
Strengths
A strong supply and distribution system helps it reach more markets and keep customers coming back.
They've made smart updates to their technology, which has helped them expand into different types of products.
They are focused on customers, which supports growth.
The company is dealing in pharma, nutrition-based products, and hygiene.
Risks
A large part of their income still comes from Gujarat, so any issues in that region could hit their business hard.
They mostly depend on a few big buyers and suppliers, and there aren’t firm contracts in place with them.
If the cost of any raw materials increases, it will decrease profits.
They need enough working capital to run things smoothly.
As of 8 August 2025, the GMP stood at ₹17. With the clock ticking and subscriptions piling in, is it worth investing? Get Medistep healthcare IPO review and check GMP updates before you make your move.
Apply today for a Medistep Healthcare IPO. Also, get access to the live subscription details.
1. Is Medistep Healthcare IPO review good or bad?
You must observe the company’s industry experience and promising financials for a better review. But some raise cautious notes around competitive pressure or business scale. Also, don't forget to check live subscription details.
2. What is the Medistep Healthcare IPO price?
The IPO price band for Medistep Healthcare stands at ₹43 per share. This range sets your entry point. It’s important to compare this with peer valuations and company financials before deciding. The final price will be fixed just before the issue opens.
3. What is the Medistep Healthcare IPO date?
Medistep Healthcare’s IPO opens for subscription on 08 Aug 2025 and will close on 12 Aug 2025. Make a note to apply within this window if you're interested. Allotment and listing details will follow soon after, so stay alert to timelines.
4. What is the Medistep Healthcare IPO GMP?
The current Grey Market Premium for this IPO is approximately ₹17 per share. GMP acts as an unofficial gauge of listing sentiment, but treats it cautiously. It’s one helpful data point but not a substitute for fundamental analysis. Also, check GMP updates regularly.
5. Should I use a demat account to apply for Medistep Healthcare IPO?
Yes, using a demat account is required for applying and holding Medistep Healthcare shares after allotment. Ensure your account is active and linked with the right broker before the IPO window opens. Without it, you simply cannot participate.
.png)
